Advanced search
Publication Cover
Annals of Medicine Volume 43, 2011 - Issue 2
Submit an article Journal homepage
679
Views
13
CrossRef citations to date
0
Altmetric
DRUG FOCUS ARTICLE

Golimumab — a new tool in the armoury against inflammatory arthritis

Zoe Ash Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, UK, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, UK
&
Paul Emery Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, UK, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, Leeds, UKCorrespondence[email protected]
Pages 133-141 | Received 07 Oct 2010, Accepted 08 Dec 2010, Published online: 18 Jan 2011

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Santhi Mantravadi, Alexis Ogdie & Walter K. Kraft. (2017) Tumor necrosis factor inhibitors in psoriatic arthritis. Expert Review of Clinical Pharmacology 10:8, pages 899-910.
Read now
Sumita Phatak, Rupesh Agrawal & Carlos Pavesio. (2014) Adalimumab: viable treatment option for pediatric refractory uveitis?. Expert Review of Ophthalmology 9:3, pages 175-184.
Read now
Fabiola Atzeni & Piercarlo Sarzi-Puttini. (2012) Twelve years’ experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practice. Expert Review of Clinical Immunology 8:3, pages 213-222.
Read now

Articles from other publishers (10)

E. V. Voronina, N. V. Lobanova, I. R. Yakhin, N. A. Romanova & Yu. A. Seregin. (2018) ROLE OF TUMOR NECROSIS FACTOR ALPHA IN IMMUNE PATHOGENESIS OF DIFFERENT DISEASES AND ITS SIGNIFICANCE FOR EVOLVING ANTICYTOKINE THERAPY WITH MONOCLONAL ANTIBODIES. Medical Immunology (Russia) 20:6, pages 797-806.
Crossref
Andrea Rubbert-Roth, Fabiola Atzeni, Ignazio Francesco Masala, Roberto Caporali, Carlomaurizio Montecucco & Piercarlo Sarzi-Puttini. (2018) TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?. Autoimmunity Reviews 17:1, pages 24-28.
Crossref
M. Jennifer Derebery, Laurel M. Fisher, Courtney C. J. Voelker & Audrey Calzada. (2014) An Open Label Study to Evaluate the Safety and Efficacy of Intratympanic Golimumab Therapy in Patients With Autoimmune Inner Ear Disease. Otology & Neurotology 35:9, pages 1515-1521.
Crossref
Miguel Cordero-Coma, Vanesa Calvo-Río, Alfredo Adán, Ricardo Blanco, Carolina Álvarez-Castro, Marina Mesquida, Sara Calleja, Miguel A. González-Gay & José G. Ruíz de Morales. (2014) Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience. Mediators of Inflammation 2014, pages 1-5.
Crossref
Ziv Rosman, Yehuda Shoenfeld & Gisele Zandman-Goddard. (2013) Biologic therapy for autoimmune diseases: an update. BMC Medicine 11:1.
Crossref
Fabiola Atzeni, Maurizio Benucci, Salvatore Sallì, Sara Bongiovanni, Laura Boccassini & Piercarlo Sarzi-Puttini. (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmunity Reviews 12:5, pages 575-579.
Crossref
Mridula William, Sepideh Faez, George N. Papaliodis & Ann-Marie Lobo. (2012) Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis. Journal of Ophthalmic Inflammation and Infection 2:4, pages 231-233.
Crossref
. (2012) Current World Literature. Current Opinion in Rheumatology 24:3, pages 342-349.
Crossref
. (2012) Bibliography Current World Literature. Current Orthopaedic Practice 23:2, pages i-x.
Crossref
Miguel Cordero-Coma, David Salom, Manuel Díaz-Llopis, María J. López-Prats & Sara Calleja. (2011) Golimumab for Uveitis. Ophthalmology 118:9, pages 1892.e3-1892.e4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.